Professional Documents
Culture Documents
Chapter 12 Synovial Fluid
Chapter 12 Synovial Fluid
Chapter 12 Synovial Fluid
INTRODUCTION
Often referred to as the “ Joint Fluid” BEST ANTICOAGULANT TO USE: Sodium Heparin and Liquid EDTA
Formed as an ultrafiltrate of the across synovial membrane, into which hyaluronic Anticoagulants to be avoided: Oxalate, Powdered EDTA, Lithium Heparin because they
acid produced by synovial cells is secreted may produce artifacts that interfere with crystal analysis
Viscous fluid acting as lubricant and adhesive, and provides nutrients for the Synovial fluid specimens should be handle like STAT specimens and delivered
avascular articular cartilage immediately to the laboratory for testing to avoid alteration of chemical constituents, cell
ULTRAFILTRATE OF PLASMA with a very mucoidal substance - HYALURONIC lysis, and problems in microorganisms detection and identification
ACID If a glucose test is to be performed, the patient should be fasting for at least 6 hours prior
Largest amount in the knee cavity to collection of joint fluid. A 6 - hour fast is necessary to establish an equilibrium
between plasma and joint glucose levels
REASONS FOR ANALYSIS:
1. Diagnosis of infectious arthritis and other joint disease
2. Diagnosis and identification of SF crystals MACROSCOPIC EXAMINATION
Page 2 of 4
SYNOVIAL FLUID
10 crystal birefringence
(YELLOW) LACTATE
Calcium pyrophosphate Rhomboid Positive Pseudogout - Levels > 250 mg/dL typically associated with septic arthritis
10 crystal square, rods birefringence
(BLUE) PROTEIN
Cholesterol Notched, Negative Extracellular - Synovial fluid contains all proteins found in plasma except fibrinogen, beta 2
rhomboid plates birefringence macroglobulin and alpha 2 macroglobulin
Corticosteroid Flat, variable- Positive and Injections - Normal: 1-3 g/dL (approxiamately 1/3 of the serum value)
shaped plates negative - Increased synovial fluid protein levels:
birefringence o Ankylosing spondylitis
Calcium oxalate Envelopes Negative Renal dialysis o Arthritis
birefringence o Arthropaties that accompany Chrohn disease
Apatite (basic calcium Small particles No birefringence Osteoarthritis o Gout
phosphate) Require electron o Psoriasis
microscopy o Reiter syndrome
o Ulcerative colitis
POSITIVE AND NEGATIVE BIREFRINGENCE
Compensated polarizing microscopy uses a red compensator or full-wave plate and is URC ACID
placed between the crystal and the analyzer.The compensator separates the light ray - Parallels serum level in gout
into slow-moving and fast-moving vibrations and produces a red background
- Normal: 6 to 8 mg/dL
o NEGATIVELY BIREFRINGENT CRYSTALS
Appear YELLOW
ENZYMES
Longitudinal axes are parallel to the axis of the red-compensator
- Lactate dehydrogenase - Increased in RA, Gout, Failed arthroplasties, and infectious
plate (slow vibration)
arthritis
- Lactic acid:
o POSITIVELY BIREFRINGENT CRYSTALS
o Helpful in diagnosing septic arthritis
Longitudinal axes are perpendicular to the axis of the red-
compensator plate (slow vibration) o Normal: < 25 mg/dL
o In septic arthritis, it can be s high as 1000 mg/dL
Crystals in synovial fluid
o Normally no crystals found in the synovial fluid MICROBIOLOGIC EXAMINATION
o Causes of formation: STAINING
Decreased renal excretion that produce elevated blood levels of - Gram stain
crystallizing chemicals - Acid Fast Stain
Degeneration of cartilage and bone
Injection of medication (corticosteroid) CULTURE AND SENSITIVITY
- Routine - use to enrichment medium (Chocolate agar)
CHEMICAL EXAMINATION - Special media/culture procedure - Fungal or tubercular
GLUCOSE
- Normal: 10 mg/dL lower than blood value JOINT DISORDER
- 20 - 60 mg/dL in septic arthritis and inflammatory
- 20 - 100 mg/dL less thhan serum levels - seen in joint disorders that are classified as Classification and Pathological Significance of Joint Disorder
infectious Group Classification Pathological Significance
Page 3 of 4
SYNOVIAL FLUID
II. Inflammatory
Immunologic origin Cloudy, yellow fluid
Poor viscosity
WBCs 2,000—75,000 µL Neutrophils >50%
Decreased glucose level
Possible autoantibodies present
Page 4 of 4